期刊文献+

双腔起搏器植入术后发生无症状性心房颤动相关因素分析 被引量:8

Incidence and the risk factors of asymptomatic atrial fibrillation after DDD pacemaker implantation
原文传递
导出
摘要 目的观察植入双腔起搏器术后无症状性心房颤动的发生率,并分析影响无症状性心房颤动发生的危险因素。方法回顾性分析了2009年1月至2012年12月在山西省心血管病医院植入双腔起搏器的患者,对其进行长期随访,随访终点包括是否发生无症状性心房颤动及心血管不良事件,并分析影响无症状性心房颤动发生的独立危险因素。结果共入选408例患者,平均年龄为(69.40±11.46)岁,男252例(61.76%),平均随访(2.71±2.26)年,无症状性心房颤动的发生率为25%。对无症状性心房颤动进行多因素分析结果显示:左心房增大(RR 2.414,95%CI 1.538~3.681,P〈0.001)、合并高血压(RR 1.804,95%CI 1.224~2.659,P=0.003)、充血性心力衰竭病史(RR 2.001,95%CI 1.053~3.802,P=0.034)是无症状性心房颤动发生的独立危险因素。结论起搏器能够提高无症状性心房颤动的检出率,而左心房增大,合并高血压、充血性心力衰竭病史与无症状性心房颤动的发生密切相关。 Objective The purpose of this study was to determine the incidence and risk factors of asymptomatic atrial fibrillation in patients who received DDD pacemaker. Methods A total of 408 patients undergoing DDD pacemaker were included in the study. The primary endpoint events included the incidence of asymptomatic atrial fibrillation, the mortality and events caused by asymptomatic atrial fibrillation. Results The mean age of study patients cohort was (69.40±11.46) years old and 252 patients (61.76%) was male. Over a mean follow-up of (2.71±2.26) years, there were 105 patients (25%) occurred asymptomatic atrial fibrillation, none of patients with death or events caused by asymptomatic atrial fibrillation. In a multivariable model, the incidence of asymptomatic atrial fibrillation was strongly associated with left atrial size (RR 2.414, 95% CI 1.538-3.681, P〈0.001), hypertension (RR 1.804, 95% CI 1.224-2.659, P=0.003) and congestive heart failure (RR 2.001, 95% CI 1.053-3.802, P=0.034). Conclusion Left atrial size, hypertension and congestive heart failure was strongly associated with the incidence of asymptomatic atrial fibrillation.
出处 《中华临床医师杂志(电子版)》 CAS 2016年第5期636-640,共5页 Chinese Journal of Clinicians(Electronic Edition)
基金 山西省科技攻关项目(20140313018-1)
关键词 心脏起搏器 人工 心房颤动 危险因素 Pacemaker,artificial Atrial fibrillation Risk factors
  • 相关文献

参考文献17

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2Wen-Hang QI, Society of Cardiology, Chinese Medical Association.Retrospective investigation of hospitalized patients with atrialfibrillation in China's Mainland[J]. Int J Cardiol, 2005, 105(3):283-287.
  • 3Healey JS, Connolly SJ, Gold MR, et al. ASSERT Investigators.Subclinical atrial fibrillation and the risk of stroke[J]. N Eng J Med,2012, 366(2): 120-129.
  • 4Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features ofchronic atrial fibrillation: the Framingham study[J]. N Engl J Med,1982, 306(2): 1018-1022.
  • 5Wolf PA, Benjamin EJ, Belanger AJ, et al. Secular trends in theprevalence of atrial fibrillation: The Framingham Study[J]. Am HeartJ, 1996, 131(4): 790-795.
  • 6Wolf PA, Abbott RD, Kannel WB, et al. Atrial fibrillation as anindependent risk factor for stroke: The Framingham Study[J]. Stroke,1991, 22(8): 983-988.
  • 7Levin LA, Husberg M, Sobocinski PD, et al. Atrial fibrillation inpatients with cryptogenic stroke[J]. N Engl J Med, 2014, 370(26):2467-2477.
  • 8Decicco AE, Finkel JB, Greenspon AJ, et al. Clinical significance ofatrial fibrillation detected by cardiac implantable electronicdevices[J]. Heart Rhythm, 2014, 11(4): 719-724.
  • 9Charles D, Hadi T, Meena N, et al. Electrocardiographic monitoringfor detecting atrial fibrillation after ischemic stroke or transientischemic attack systematic review and meta-analysis[J]. CircArrhythm Electrophysiol, 2015, 8(2): 263-269.
  • 10Toff FD, Skehan JD, Bono DP, et al. The United Kingdom pacingand cardiovascular events (UKPACE) trial[J]. Heart, 1997, 73(3):221-223.

二级参考文献1

共引文献1400

同被引文献56

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部